First Trust Advisors LP Exelixis, Inc. Transaction History

First Trust Advisors LP

  • $108 Billion
  • Q1 2025

A detailed history of First Trust Advisors LP transactions in Exelixis, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 1,982,748 shares of EXEL stock, worth $85.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,982,748
Previous 2,539,863 21.93%
Holding current value
$85.4 Million
Previous $84.6 Million 13.45%
% of portfolio
0.07%
Previous 0.08%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$32.38 - $39.16 $18 Million - $21.8 Million
-557,115 Reduced 21.93%
1,982,748 $73.2 Million
Q4 2024

Feb 13, 2025
SELL
$25.39 - $36.46 $8.35 Million - $12 Million
-328,754 Reduced 11.46%
2,539,863 $84.6 Million
Q3 2024

Nov 13, 2024
BUY
$21.96 - $27.6 $6.2 Million - $7.79 Million
282,350 Added 10.92%
2,868,617 $74.4 Million
Q2 2024

Aug 13, 2024
SELL
$20.34 - $23.73 $7.88 Million - $9.19 Million
-387,315 Reduced 13.03%
2,586,267 $58.1 Million
Q1 2024

May 13, 2024
SELL
$20.17 - $23.93 $3.61 Million - $4.29 Million
-179,173 Reduced 5.68%
2,973,582 $70.6 Million
Q4 2023

Feb 13, 2024
BUY
$19.25 - $24.13 $9.48 Million - $11.9 Million
492,613 Added 18.52%
3,152,755 $75.6 Million
Q3 2023

Nov 13, 2023
SELL
$19.04 - $22.74 $26.6 Million - $31.7 Million
-1,395,960 Reduced 34.42%
2,660,142 $58.1 Million
Q2 2023

Aug 14, 2023
SELL
$18.17 - $20.48 $12.7 Million - $14.3 Million
-696,632 Reduced 14.66%
4,056,102 $77.5 Million
Q1 2023

May 15, 2023
BUY
$16.3 - $19.41 $15.1 Million - $17.9 Million
924,189 Added 24.14%
4,752,734 $92.3 Million
Q4 2022

Feb 09, 2023
BUY
$14.96 - $17.39 $2.73 Million - $3.17 Million
182,299 Added 5.0%
3,828,545 $61.4 Million
Q3 2022

Nov 14, 2022
BUY
$15.68 - $22.27 $6.02 Million - $8.55 Million
384,054 Added 11.77%
3,646,246 $57.2 Million
Q2 2022

Aug 12, 2022
SELL
$17.44 - $23.16 $5.23 Million - $6.95 Million
-300,161 Reduced 8.43%
3,262,192 $67.9 Million
Q1 2022

May 13, 2022
BUY
$17.03 - $22.67 $14.2 Million - $18.9 Million
835,621 Added 30.65%
3,562,353 $80.8 Million
Q4 2021

Feb 08, 2022
SELL
$15.84 - $21.88 $15.1 Million - $20.9 Million
-955,947 Reduced 25.96%
2,726,732 $49.8 Million
Q3 2021

Nov 15, 2021
BUY
$16.3 - $21.14 $8.38 Million - $10.9 Million
513,866 Added 16.22%
3,682,679 $77.9 Million
Q2 2021

Aug 16, 2021
SELL
$17.95 - $25.56 $6.09 Million - $8.67 Million
-339,161 Reduced 9.67%
3,168,813 $57.7 Million
Q1 2021

May 14, 2021
BUY
$20.53 - $25.22 $3.26 Million - $4.01 Million
158,831 Added 4.74%
3,507,974 $79.2 Million
Q4 2020

Feb 02, 2021
SELL
$18.39 - $24.8 $11.4 Million - $15.4 Million
-619,460 Reduced 15.61%
3,349,143 $67.2 Million
Q3 2020

Nov 05, 2020
SELL
$20.67 - $26.94 $7.5 Million - $9.77 Million
-362,635 Reduced 8.37%
3,968,603 $97 Million
Q2 2020

Jul 22, 2020
SELL
$16.46 - $27.42 $10.5 Million - $17.4 Million
-635,902 Reduced 12.8%
4,331,238 $103 Million
Q1 2020

May 06, 2020
BUY
$14.46 - $21.8 $8.23 Million - $12.4 Million
568,921 Added 12.94%
4,967,140 $85.5 Million
Q4 2019

Feb 03, 2020
BUY
$15.15 - $18.89 $5.65 Million - $7.05 Million
373,013 Added 9.27%
4,398,219 $77.5 Million
Q3 2019

Nov 04, 2019
SELL
$17.68 - $22.65 $32.5 Million - $41.7 Million
-1,840,431 Reduced 31.38%
4,025,206 $71.2 Million
Q2 2019

Jul 30, 2019
BUY
$18.93 - $24.75 $8.2 Million - $10.7 Million
433,202 Added 7.97%
5,865,637 $125 Million
Q1 2019

May 09, 2019
SELL
$19.6 - $24.76 $2.33 Million - $2.94 Million
-118,703 Reduced 2.14%
5,432,435 $129 Million
Q4 2018

Feb 07, 2019
BUY
$13.65 - $21.8 $12.4 Million - $19.8 Million
907,412 Added 19.54%
5,551,138 $109 Million
Q3 2018

Oct 25, 2018
BUY
$15.87 - $22.4 $32.4 Million - $45.8 Million
2,044,201 Added 78.64%
4,643,726 $82.3 Million
Q2 2018

Aug 02, 2018
BUY
$18.56 - $22.45 $32 Million - $38.8 Million
1,726,507 Added 197.76%
2,599,525 $55.9 Million
Q1 2018

Apr 23, 2018
BUY
$22.15 - $31.89 $5.26 Million - $7.57 Million
237,256 Added 37.32%
873,018 $19.3 Million
Q4 2017

Feb 08, 2018
SELL
$24.23 - $30.93 $10.9 Million - $13.9 Million
-450,373 Reduced 41.47%
635,762 $19.3 Million
Q3 2017

Oct 24, 2017
BUY
$23.35 - $29.24 $25.4 Million - $31.8 Million
1,086,135
1,086,135 $26.3 Million

Others Institutions Holding EXEL

# of Institutions
611
Shares Held
257M
Call Options Held
1.57M
Put Options Held
730K
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email